Transgene Biotek Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported revenue was INR 0.43847 million compared to INR 1.66 million a year ago. Net loss was INR 14.72 million compared to INR 25.45 million a year ago.

Basic loss per share from continuing operations was INR 0.19 compared to INR 0.34 a year ago. Diluted loss per share from continuing operations was INR 0.19 compared to INR 0.34 a year ago.